Cytek Biosciences Statistics
Total Valuation
CTKB has a market cap or net worth of $814.08 million. The enterprise value is $550.82 million.
Important Dates
The last earnings date was Tuesday, November 5, 2024, after market close.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CTKB has 128.81 million shares outstanding. The number of shares has decreased by -2.89% in one year.
| Current Share Class | 128.81M |
| Shares Outstanding | 128.81M |
| Shares Change (YoY) | -2.89% |
| Shares Change (QoQ) | +1.02% |
| Owned by Insiders (%) | 8.93% |
| Owned by Institutions (%) | 53.38% |
| Float | 110.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 25.45 |
| PS Ratio | 4.14 |
| Forward PS | 3.59 |
| PB Ratio | 2.13 |
| P/TBV Ratio | 2.33 |
| P/FCF Ratio | 28.30 |
| P/OCF Ratio | 24.75 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 19.15 |
Financial Position
The company has a current ratio of 6.21, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.21 |
| Quick Ratio | 5.26 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.50 |
| Interest Coverage | -20.35 |
Financial Efficiency
Return on equity (ROE) is -2.54% and return on invested capital (ROIC) is -3.33%.
| Return on Equity (ROE) | -2.54% |
| Return on Assets (ROA) | -2.74% |
| Return on Capital (ROIC) | -3.33% |
| Revenue Per Employee | $297,648 |
| Profits Per Employee | -$15,030 |
| Employee Count | 676 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.59 |
Taxes
| Income Tax | -1.75M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.47% in the last 52 weeks. The beta is 1.46, so CTKB's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -33.47% |
| 50-Day Moving Average | 6.03 |
| 200-Day Moving Average | 5.92 |
| Relative Strength Index (RSI) | 49.18 |
| Average Volume (20 Days) | 646,830 |
Short Selling Information
The latest short interest is 3.95 million, so 3.07% of the outstanding shares have been sold short.
| Short Interest | 3.95M |
| Short Previous Month | 4.11M |
| Short % of Shares Out | 3.07% |
| Short % of Float | 3.57% |
| Short Ratio (days to cover) | 4.50 |
Income Statement
In the last 12 months, CTKB had revenue of $201.21 million and -$10.16 million in losses. Loss per share was -$0.08.
| Revenue | 201.21M |
| Gross Profit | 110.50M |
| Operating Income | -22.15M |
| Pretax Income | -16.25M |
| Net Income | -10.16M |
| EBITDA | -15.16M |
| EBIT | -22.15M |
| Loss Per Share | -$0.08 |
Full Income StatementBalance Sheet
The company has $277.78 million in cash and $14.52 million in debt, giving a net cash position of $263.26 million or $2.04 per share.
| Cash & Cash Equivalents | 277.78M |
| Total Debt | 14.52M |
| Net Cash | 263.26M |
| Net Cash Per Share | $2.04 |
| Equity (Book Value) | 385.46M |
| Book Value Per Share | 2.97 |
| Working Capital | 327.39M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $32.89 million and capital expenditures -$4.13 million, giving a free cash flow of $28.76 million.
| Operating Cash Flow | 32.89M |
| Capital Expenditures | -4.13M |
| Free Cash Flow | 28.76M |
| FCF Per Share | $0.22 |
Full Cash Flow StatementMargins
Gross margin is 54.92%, with operating and profit margins of -11.01% and -5.05%.
| Gross Margin | 54.92% |
| Operating Margin | -11.01% |
| Pretax Margin | -5.92% |
| Profit Margin | -5.05% |
| EBITDA Margin | -7.53% |
| EBIT Margin | -11.01% |
| FCF Margin | 14.30% |
Dividends & Yields
CTKB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.89% |
| Shareholder Yield | 2.89% |
| Earnings Yield | -1.25% |
| FCF Yield | 3.53% |
Analyst Forecast
The average price target for CTKB is $9.17, which is 45.10% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.17 |
| Price Target Difference | 45.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTKB has an Altman Z-Score of 5.81 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.81 |
| Piotroski F-Score | 4 |